| Symbol | RGBP |
|---|---|
| Name | REGEN BIOPHARMA, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 91942 United States CA 4700 Spring Street St 304 |
| Telephone | (619) 722 5505 |
| Fax | — |
| — | |
| Website | http://www.regenbiopharmainc.com/ |
| Incorporation | US |
| Incorporated On | 2012 |
| Employees | — |
| Fiscal Year | 9/30 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001589150 |
| Description | Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com. Additional info from OTC: |
New Form QUALIF - Regen BioPharma Inc Filed: 2026-01-12 AccNo: 9999999994-26-000013 Size: 1 KB
Read moreNew Form 1-A POS - Regen BioPharma Inc Filed: 2026-01-08 AccNo: 0001493152-26-000934 Size: 1 MB
Read moreNew Form 10-K - Regen BioPharma Inc Filed: 2025-12-30 AccNo: 0001493152-25-029526 Size: 7 MB
Read morePenumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
Read moreNew Form 253G1 - Regen BioPharma Inc Filed: 2025-12-05 AccNo: 0001493152-25-026350 Size: 2 MB
Read moreNew Form QUALIF - Regen BioPharma Inc Filed: 2025-12-03 AccNo: 9999999994-25-000213 Size: 1 KB
Read more